Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at ASCO and ESMO for 2021.
For this series, the doctors discuss new trials for patients with NSCLC. The doctors discuss IMpower010, and Adjuvant Atezolizumab After Chemotherapy in Resected Stage I-IIIA NSCLC.
For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.